Keros Therapeutics (KROS) Receivables Refunds (2025)
Keros Therapeutics' Receivables Refunds history spans 1 years, with the latest figure at $2.2 million for Q4 2025.
- For Q4 2025, Receivables Refunds changed N/A year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, changed N/A, while the annual FY2025 figure was $2.2 million, N/A changed from the prior year.
- Receivables Refunds reached $2.2 million in Q4 2025 per KROS's latest filing.
- In the past five years, Receivables Refunds ranged from a high of $2.2 million in Q4 2025 to a low of $2.2 million in Q4 2025.